Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongming Zhu

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Frontiers of Medicine|September 12, 2022
Predictive values of plasma TNFα and IL-8 for intracranial hemorrhage in patients with acute promyelocytic leukemiaFangyi Dong, Li Chen, Chaoxian Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 18, 2026
Engineering CLL-1 CAR-NK cells via mRNA-LNP for potent antitumor activity and reversal of HLA-E-mediated resistance in acute myeloid leukemiaJie Shen, Peng Jin, Yebing Liang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2018
Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathwaysXiaoting Liang, Yue Ding, Fang Lin, et al.
Future Oncology (London, England)|February 26, 2025
Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocolYunxiang Zhang, Min Wu, Zhen Jin, et al.
Heliyon|November 7, 2024
SS-31 modification alleviates ferroptosis induced by superparamagnetic iron oxide nanoparticles in hypoxia/reoxygenation cardiomyocytesQizheng Lu, Xiaobo Yao, Hao Zheng, et al.
Cell Reports|September 4, 2025
Transcript isoform diversity defines molecular subtypes and prognosis in acute myeloid leukemia through long-read sequencingXiaoguang Shi, Shuai Wang, Shuting Yu, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 23, 2023
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphomaZhen Jin, Rufang Xiang, Kai Qing, et al.
Frontiers in Immunology|September 30, 2024
A CD8<sup>+</sup> T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemiaZeyi Li, Peng Jin, Rufang Xiang, et al.
Chemotherapy|November 29, 2021
Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaKai Qing, Zhen Jin, Zizhen Xu, et al.
Science Bulletin|December 22, 2022
A simple, rapid, and practical method for single-cell proteomics based on mass-adaptive coating of synthetic peptidesSiqi Li, Kaichan Su, Zhenkun Zhuang, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Frontiers of Medicine|September 12, 2022
Predictive values of plasma TNFα and IL-8 for intracranial hemorrhage in patients with acute promyelocytic leukemiaFangyi Dong, Li Chen, Chaoxian Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 18, 2026
Engineering CLL-1 CAR-NK cells via mRNA-LNP for potent antitumor activity and reversal of HLA-E-mediated resistance in acute myeloid leukemiaJie Shen, Peng Jin, Yebing Liang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2018
Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathwaysXiaoting Liang, Yue Ding, Fang Lin, et al.
Future Oncology (London, England)|February 26, 2025
Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocolYunxiang Zhang, Min Wu, Zhen Jin, et al.
Heliyon|November 7, 2024
SS-31 modification alleviates ferroptosis induced by superparamagnetic iron oxide nanoparticles in hypoxia/reoxygenation cardiomyocytesQizheng Lu, Xiaobo Yao, Hao Zheng, et al.
Cell Reports|September 4, 2025
Transcript isoform diversity defines molecular subtypes and prognosis in acute myeloid leukemia through long-read sequencingXiaoguang Shi, Shuai Wang, Shuting Yu, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 23, 2023
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphomaZhen Jin, Rufang Xiang, Kai Qing, et al.
Frontiers in Immunology|September 30, 2024
A CD8<sup>+</sup> T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemiaZeyi Li, Peng Jin, Rufang Xiang, et al.
Chemotherapy|November 29, 2021
Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaKai Qing, Zhen Jin, Zizhen Xu, et al.
Science Bulletin|December 22, 2022
A simple, rapid, and practical method for single-cell proteomics based on mass-adaptive coating of synthetic peptidesSiqi Li, Kaichan Su, Zhenkun Zhuang, et al.
Pageof 8